DE60204322D1 - Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen - Google Patents

Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen

Info

Publication number
DE60204322D1
DE60204322D1 DE60204322T DE60204322T DE60204322D1 DE 60204322 D1 DE60204322 D1 DE 60204322D1 DE 60204322 T DE60204322 T DE 60204322T DE 60204322 T DE60204322 T DE 60204322T DE 60204322 D1 DE60204322 D1 DE 60204322D1
Authority
DE
Germany
Prior art keywords
treatment
nitrogen monoxide
forming compositions
nail bed
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60204322T
Other languages
English (en)
Other versions
DE60204322T2 (de
Inventor
Nigel Benjamin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Aberdeen
Original Assignee
University of Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Aberdeen filed Critical University of Aberdeen
Publication of DE60204322D1 publication Critical patent/DE60204322D1/de
Application granted granted Critical
Publication of DE60204322T2 publication Critical patent/DE60204322T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE60204322T 2001-08-03 2002-08-02 Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen Expired - Lifetime DE60204322T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0119011.5A GB0119011D0 (en) 2001-08-03 2001-08-03 Treatment of nail infections
GB0119011 2001-08-03
PCT/GB2002/003575 WO2003013489A1 (en) 2001-08-03 2002-08-02 Treatment of nail infections with no

Publications (2)

Publication Number Publication Date
DE60204322D1 true DE60204322D1 (de) 2005-06-30
DE60204322T2 DE60204322T2 (de) 2006-01-26

Family

ID=9919789

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60204322T Expired - Lifetime DE60204322T2 (de) 2001-08-03 2002-08-02 Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen

Country Status (23)

Country Link
US (2) US20050037093A1 (de)
EP (1) EP1411908B1 (de)
JP (1) JP2005501069A (de)
KR (1) KR20040031780A (de)
CN (1) CN1321633C (de)
AT (1) ATE296094T1 (de)
AU (1) AU2002318001B2 (de)
BR (1) BR0211390A (de)
CA (1) CA2453243C (de)
DE (1) DE60204322T2 (de)
ES (1) ES2242042T3 (de)
GB (1) GB0119011D0 (de)
HR (1) HRP20040059B1 (de)
HU (1) HUP0401190A3 (de)
IL (2) IL159724A0 (de)
MX (1) MXPA04000670A (de)
NO (1) NO20040258L (de)
NZ (1) NZ530577A (de)
PL (1) PL213555B1 (de)
PT (1) PT1411908E (de)
RU (1) RU2298403C2 (de)
WO (1) WO2003013489A1 (de)
ZA (1) ZA200400491B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
WO2005007173A1 (en) 2003-07-09 2005-01-27 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
DE602006006432D1 (de) 2005-03-24 2009-06-04 Nolabs Ab Kosmetische behandlung mit stickoxid, vorrichtung zur durchführung dieser behandlung und herstellungsverfahren dafür
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
CA2606565C (en) 2005-05-27 2016-05-10 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
JP5165217B2 (ja) * 2006-07-07 2013-03-21 生化学工業株式会社 ゲル状又はフィルム状組成物並びにその製造方法及び用途
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
WO2009055008A1 (en) * 2007-10-24 2009-04-30 Wharton Innovative Products, Llc Two part lotion for the delivery of nitrite ions to the skin
AU2008322437B2 (en) 2007-11-15 2013-11-07 Louisiana State University Use of nitrite salts in chronic ischemia
JP2011507968A (ja) * 2007-12-27 2011-03-10 エイヤーズ ファーマシューティカルズ、インク． エアロゾル化ニトライトおよび一酸化窒素供与性化合物ならびにそれらの使用
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
WO2010044875A2 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
CA2740135A1 (en) * 2008-10-30 2010-05-06 Chris Miller Wound dressings comprising a nitric oxide gas producing component and an oxygen releasing component
DK2467173T3 (da) 2009-08-21 2019-07-29 Novan Inc Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf
US9526738B2 (en) 2009-08-21 2016-12-27 Novan, Inc. Topical gels and methods of using the same
EP2488591A1 (de) * 2009-10-13 2012-08-22 Novan, Inc. Stickoxidfreisetzende beschichtungen
CA2777066C (en) * 2009-10-14 2020-02-18 TheraVasc, LLC Pharmaceutical formulations of nitrite and uses thereof
EP2575829A4 (de) * 2010-06-07 2014-04-30 Topical Pharma Ab Kit zur behandlung von onychomykose durch stickoxid
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
EP2681286B1 (de) 2011-02-28 2018-08-15 Novan, Inc. Stickoxid-freisetzende s-nitrosothiol-modifizierte kieselsäureteilchen und verfahren zu ihrer herstellung
WO2012131412A2 (en) 2011-03-31 2012-10-04 Szabo Laszlo Gabor Pharmaceutical composition containing no, process for the preparation and use thereof
WO2013006608A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Topical compositions
US9737362B2 (en) * 2011-07-06 2017-08-22 Boston Scientific Scimed, Inc. Tissue cutting systems and methods
KR20140053342A (ko) 2011-08-17 2014-05-07 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 경구 전달 시스템을 통해 생리학적 및 치료학적 수준의 일산화질소를 생산하는 방법
BR112014021501B1 (pt) 2012-03-14 2020-12-08 Novan, Inc composição farmacêutica para administração tópica de um ingrediente farmacêutico ativo ativado por umidade
ES2741146T3 (es) 2013-02-20 2020-02-10 The Board Of Supervisors Of The Louisiana State Univ Mechanical And Agricultural College Formulaciones farmacéuticas de nitrio y sus usos
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US9095518B2 (en) 2013-08-01 2015-08-04 Liqwd, Inc. Methods for fixing hair and skin
KR102428738B1 (ko) 2013-08-08 2022-08-02 노반, 인크. 국소 조성물 및 그의 사용 방법
WO2016022170A1 (en) 2014-08-08 2016-02-11 Novan, Inc. Topical emulsions
EP4249431A3 (de) * 2014-03-14 2023-11-29 SaNOtize Research and Development Corp. Zusammensetzungen und verfahren zur behandlung von krankheiten oder störungen unter verwendung von lösungen mit verlängerter stickoxidfreisetzung
PT3142637T (pt) 2014-05-16 2020-10-15 Olaplex Inc Formulações e métodos de tratamento de queratina
JP6651499B2 (ja) 2014-07-11 2020-02-19 ノヴァン，インコーポレイテッド 局所用抗ウイルス薬組成物及びこれを使用する方法
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
US10925689B2 (en) 2014-07-14 2021-02-23 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
WO2016172708A1 (en) 2015-04-24 2016-10-27 Liqwd, Inc. Methods for treating relaxed hair
US10849864B2 (en) 2015-07-28 2020-12-01 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
US10912743B2 (en) 2016-03-02 2021-02-09 Novan, Inc. Compositions for treating inflammation and methods of treating the same
WO2017180822A1 (en) 2016-04-13 2017-10-19 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
US9872821B1 (en) 2016-07-12 2018-01-23 Liqwd, Inc. Methods and formulations for curling hair
US11534382B2 (en) 2017-06-19 2022-12-27 Novan, Inc. Topical compositions and methods of using the same
CN112165935A (zh) 2018-03-01 2021-01-01 诺万公司 一氧化氮释放性栓剂及其使用方法
WO2019175674A2 (en) 2018-03-13 2019-09-19 Regev Gilly Nitric oxide releasing compositions
RU2704782C1 (ru) * 2018-10-09 2019-10-30 Елена Владимировна Герасимчук Способ криогенного лечения онихомикоза
CA3142109A1 (en) 2019-06-04 2020-12-10 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
BR112021023832A8 (pt) 2019-06-04 2023-02-28 Thirty Holdings Ltd Métodos e composições para geração de óxido nítrico e usos dos mesmos
AU2021259360A1 (en) 2020-04-23 2022-12-01 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating SARS-CoV and SARS-CoV-2
GB2610721B (en) 2020-04-23 2024-07-31 Thirty Respiratory Ltd Compositions for treating and combatting tuberculosis
CN116615188A (zh) * 2020-07-16 2023-08-18 萨诺蒂泽研究开发公司 治疗对一氧化氮疗法有反应的状况的方法
RU2769437C1 (ru) * 2021-07-08 2022-03-31 Светлана Николаевна Абрамова Способ восстановления роста ногтя

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY128187A (en) * 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
AU693851B2 (en) * 1994-02-21 1998-07-09 Aberdeen University Acidified nitrite as an antimicrobial agent
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide

Also Published As

Publication number Publication date
KR20040031780A (ko) 2004-04-13
US20050037093A1 (en) 2005-02-17
HUP0401190A3 (en) 2008-08-28
HRP20040059B1 (en) 2008-05-31
US9381381B2 (en) 2016-07-05
RU2004101765A (ru) 2005-03-10
HRP20040059A2 (en) 2004-08-31
ZA200400491B (en) 2005-04-22
DE60204322T2 (de) 2006-01-26
CN1321633C (zh) 2007-06-20
NZ530577A (en) 2007-01-26
CN1564681A (zh) 2005-01-12
IL159724A (en) 2006-04-10
US20100015253A1 (en) 2010-01-21
BR0211390A (pt) 2004-08-17
NO20040258L (no) 2004-03-29
PL366579A1 (en) 2005-02-07
CA2453243C (en) 2012-01-03
CA2453243A1 (en) 2003-02-20
IL159724A0 (en) 2004-06-20
ATE296094T1 (de) 2005-06-15
ES2242042T3 (es) 2005-11-01
EP1411908A1 (de) 2004-04-28
WO2003013489A1 (en) 2003-02-20
EP1411908B1 (de) 2005-05-25
RU2298403C2 (ru) 2007-05-10
JP2005501069A (ja) 2005-01-13
PL213555B1 (pl) 2013-03-29
AU2002318001B2 (en) 2007-02-15
HUP0401190A2 (hu) 2004-11-29
GB0119011D0 (en) 2001-09-26
PT1411908E (pt) 2005-08-31
MXPA04000670A (es) 2004-10-27

Similar Documents

Publication Publication Date Title
DE60204322D1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
NO20055741L (no) Nye kjemiske forbindelser
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
TW200510416A (en) P38 inhibitors and methods of use thereof
TW200514776A (en) Aminotriazole compounds useful as inhibitors of protein kinases
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
MXPA05011522A (es) Derivados de 2-acilamino-4-feniltiazol, metodo para su preparacion y su aplicacion en terapeutica.
ATE441632T1 (de) Gesättigte und ungesättigte 3-pyridyl- benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
ATE429228T1 (de) Derivate von piperazine-2-carboxamide
EP1423414A4 (de) Neue depsipeptide und verfahren zu deren herstellung
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
CY1113871T1 (el) Διαδικασια παρασκευης γκαμπαπεντινης
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
EA200701852A1 (ru) Производные аминокислот
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
NO20062229L (no) Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er)
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
ATE476987T1 (de) Zusammensetzungen und methoden zur behandlung von candidosen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition